Equities

Organogenesis Holdings Inc

Organogenesis Holdings Inc

Actions
  • Price (EUR)3.02
  • Today's Change0.02 / 0.67%
  • Shares traded150.00
  • 1 Year change+58.12%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments104102114
Total Receivables, Net828982
Total Inventory282525
Prepaid expenses105.094.97
Other current assets, total0.500.810.60
Total current assets225223227
Property, plant & equipment, net156146128
Goodwill, net292929
Intangibles, net162126
Long term investments------
Note receivable - long term------
Other long term assets5.991.521.54
Total assets460449443
LIABILITIES
Accounts payable313229
Accrued expenses433848
Notes payable/short-term debt000
Current portion long-term debt/capital leases6.574.542.86
Other current liabilities, total--01.44
Total current liabilities817582
Total long term debt636671
Total debt697174
Deferred income tax------
Minority interest------
Other liabilities, total384248
Total liabilities181184201
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital320311302
Retained earnings (accumulated deficit)(41)(45)(60)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity279266242
Total liabilities & shareholders' equity460449443
Total common shares outstanding131131129
Treasury shares - common primary issue0.730.730.73
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.